Joseph Fralin Woody, Director at AVITA Medical, Inc. (RCEL), bought 20,000 shares at $4.34 ($85K) on 2026-06-01, disclosed to the SEC on 2026-06-03.
Director Joseph Fralin Woody purchased 5,000 shares at $4.34, marking the largest insider purchase in the company's history. This significant buyback occurs as the stock trades near its 52-week low, potentially signaling confidence in the recovery of the RECELL product line.
The stock is currently trading at $4.195, down 28.41% over the past year and sitting 41.08% below its 52-week high of $7.12.
The stock carries high volatility with a beta of 1.898 and faces margin pressure risks as noted in the May 15 earnings call.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.26 | 5,000 | $21K | 25.1% |
| 2 | $4.34 | 5,000 | $22K | 25.5% |
| 3 | $4.18 | 5,000 | $21K | 24.6% |
| 4 | $4.21 | 5,000 | $21K | 24.8% |
| Total | $4.25 avg | 20,000 | $85K | 100% |
| Filing → |
| RCEL | BUY | 2026-06-05 | $41K | — | Filing → |
| AVNS | BUY | 2019-06-03 | $140K | — | Filing → |
| AVNS | BUY | 2018-11-29 | $152K | — | Filing → |